160 related articles for article (PubMed ID: 6444322)
1. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis).
Puhvel SM; Sakamoto M
J Invest Dermatol; 1980 Jan; 74(1):36-9. PubMed ID: 6444322
[TBL] [Abstract][Full Text] [Related]
2. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism.
Akamatsu H; Niwa Y; Kurokawa I; Masuda R; Nishijima S; Asada Y
Arch Dermatol Res; 1991; 283(8):524-8. PubMed ID: 1838472
[TBL] [Abstract][Full Text] [Related]
3. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.
Webster GF; Leyden JJ; Norman ME; Nilsson UR
Infect Immun; 1978 Nov; 22(2):523-9. PubMed ID: 153333
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin.
Akamatsu H; Kurokawa I; Nishijima S; Asada Y
Dermatology; 1992; 185(1):41-3. PubMed ID: 1386264
[TBL] [Abstract][Full Text] [Related]
5. Porphyrin Production and Regulation in Cutaneous Propionibacteria.
Barnard E; Johnson T; Ngo T; Arora U; Leuterio G; McDowell A; Li H
mSphere; 2020 Jan; 5(1):. PubMed ID: 31941813
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of Propionibacterium acnes and other skin organisms.
Allaker RP; Greenman J; Osborne RH; Gowers JI
Br J Dermatol; 1985 Aug; 113(2):229-35. PubMed ID: 3161535
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.
Knop J; Bossecker T; Kövary PM
Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635
[TBL] [Abstract][Full Text] [Related]
8. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
Ashbee HR; Muir SR; Cunliffe WJ; Ingham E
Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507
[TBL] [Abstract][Full Text] [Related]
9. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions.
Holland KT; Cunliffe WJ; Eady EA
J Med Microbiol; 1979 Feb; 12(1):71-82. PubMed ID: 34728
[TBL] [Abstract][Full Text] [Related]
10. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.
Webster GF; Leyden JJ; McGinley KJ; McArthur WP
Antimicrob Agents Chemother; 1982 May; 21(5):770-2. PubMed ID: 7049078
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Activity of Pomegranate and Green Tea Extract on Propionibacterium Acnes, Propionibacterium Granulosum, Staphylococcus Aureus and Staphylococcus Epidermidis.
Li Z; Summanen PH; Downes J; Corbett K; Komoriya T; Henning SM; Kim J; Finegold SM
J Drugs Dermatol; 2015 Jun; 14(6):574-8. PubMed ID: 26091382
[TBL] [Abstract][Full Text] [Related]
12. The chemoattractant properties of comedonal components.
Puhvel SM; Sakamoto M
J Invest Dermatol; 1978 Nov; 71(5):324-9. PubMed ID: 152335
[TBL] [Abstract][Full Text] [Related]
13. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
[TBL] [Abstract][Full Text] [Related]
14. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis.
Christensen GJ; Scholz CF; Enghild J; Rohde H; Kilian M; Thürmer A; Brzuszkiewicz E; Lomholt HB; Brüggemann H
BMC Genomics; 2016 Feb; 17():152. PubMed ID: 26924200
[TBL] [Abstract][Full Text] [Related]
15. Esterification of (4--14C)cholesterol by cutaneous bacteria (Staphylococcus epidermidis, Propionibacterium acnes, and Propionibacterium granulosum).
Puhvel SM
J Invest Dermatol; 1975 Jun; 64(6):397-400. PubMed ID: 1141713
[TBL] [Abstract][Full Text] [Related]
16. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
Białecka A; Mak M; Biedroń R; Bobek M; Kasprowicz A; Marcinkiewicz J
Arch Immunol Ther Exp (Warsz); 2005; 53(1):79-85. PubMed ID: 15761379
[TBL] [Abstract][Full Text] [Related]
17. Anti-P. acnes antibody in comedonal extracts.
Knop J; Ollefs K; Frosch PJ
J Invest Dermatol; 1983 Jan; 80(1):9-12. PubMed ID: 6217259
[TBL] [Abstract][Full Text] [Related]
18. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous visualization of Propionibacterium acnes and Propionibacterium granulosum with immunofluorescence and fluorescence in situ hybridization.
Jahns AC; Oprica C; Vassilaki I; Golovleva I; Palmer RH; Alexeyev OA
Anaerobe; 2013 Oct; 23():48-54. PubMed ID: 23896347
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of the Propionibacterium strains isolated from acne patients].
Białecka A; Kasprowicz A; Kaszycki P; Marcinkiewicz J
Med Dosw Mikrobiol; 2004; 56(1):79-92. PubMed ID: 15524399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
